BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Gufic BioSciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
509079
ISIN Demat
INE742B01025
Book Value (Rs)
66.2307167
NSE Symbol
GUFICBIO
Divident Yield %
0.02
Market Cap
(Rs In Cr.)
4,234
P/E (TTM)
67.02
EPS (TTM)
6.3
Face Value
(Rs)
1
Back
Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter
01-Jun-26   Hrs IST

Net profit of Gufic BioSciences rose 183.68% to Rs 21.90 crore in the quarter ended March 2026 as against Rs 7.72 crore during the previous quarter ended March 2025. Sales rose 22.83% to Rs 251.82 crore in the quarter ended March 2026 as against Rs 205.02 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.81% to Rs 64.21 crore in the year ended March 2026 as against Rs 69.65 crore during the previous year ended March 2025. Sales rose 15.15% to Rs 944.01 crore in the year ended March 2026 as against Rs 819.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales251.82205.02 23 944.01819.81 15
OPM %18.7512.87 -16.0316.60 -
PBDT36.6018.37 99 117.38115.21 2
PBT28.9510.52 175 86.5594.14 -8
NP21.907.72 184 64.2169.65 -8

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)